Baillie Gifford & CO Illumina, Inc. Transaction History
Baillie Gifford & CO
- $111 Billion
- Q1 2025
A detailed history of Baillie Gifford & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Baillie Gifford & CO holds 3,010,792 shares of ILMN stock, worth $293 Million. This represents 0.22% of its overall portfolio holdings.
Number of Shares
3,010,792
Previous 3,018,193
0.25%
Holding current value
$293 Million
Previous $403 Million
40.77%
% of portfolio
0.22%
Previous 0.32%
Shares
32 transactions
Others Institutions Holding ILMN
# of Institutions
855Shares Held
153MCall Options Held
1.52MPut Options Held
1.24M-
Capital World Investors Los Angeles, CA18.9MShares$1.84 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY18.1MShares$1.76 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.4MShares$1.6 Billion0.02% of portfolio
-
State Street Corp Boston, MA5.85MShares$570 Million0.02% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA4.18MShares$407 Million0.96% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $15.3B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....